Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Improved method for collection of sputum for tuberculosis testing to ensure adequate sample volumes for molecular diagnostic testing.

Journal of microbiological methods·2017

Same author

Non-oncogenic Acute Viral Infections Disrupt Anti-cancer Responses and Lead to Accelerated Cancer-Specific Host Death.

Cell reports·2016

Same author

A new patient-operated sampling device for measurement of aeroallergens.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2016

Same author

NK cells and CD8+ T cells cooperate to improve therapeutic responses in melanoma treated with interleukin-2 (IL-2) and CTLA-4 blockade.

Journal for immunotherapy of cancer·2015

Same author

HIV Infection Leads to Redistribution of Leaky Claudin-2 in the Intestine of Humanized SCID IL-2R(-/-) Hu-PBMC Mice.

AIDS research and human retroviruses·2015

Same author

HIV infection accelerates gastrointestinal tumor outgrowth in NSG-HuPBL mice.

AIDS research and human retroviruses·2014

Search research articles

Related Experiment Video

Updated: Jun 18, 2026

Fluorescent Lateral Flow Immunoassay Based on Quantum Dots Nanobeads

Fluorescent Lateral Flow Immunoassay Based on Quantum Dots Nanobeads

Published on: June 28, 2024

A lateral flow-based ultra-sensitive p24 HIV assay utilizing fluorescent microparticles.

Arman Nabatiyan¹, Michael A Baumann, Zaheer Parpia

¹Department of Biomedical Engineering, Center for Innovation in Global Health Technologies, Northwestern University, 2145 Sheridan Road, Evanston, IL 60208, USA. arman@northwestern.edu

Journal of Acquired Immune Deficiency Syndromes (1999)

|November 21, 2009

Summary

A new lateral flow assay for HIV p24 antigen offers high sensitivity and rapid results, addressing limitations of current diagnostic tests in resource-limited settings. This breakthrough improves HIV detection accessibility and speed.

More Related Videos

Multiplexed Isothermal Amplification Based Diagnostic Platform to Detect Zika, Chikungunya, and Dengue 1

Multiplexed Isothermal Amplification Based Diagnostic Platform to Detect Zika, Chikungunya, and Dengue 1

Published on: March 13, 2018

Computer Numerical Control Micromilling of a Microfluidic Acrylic Device with a Staggered Restriction for Magnetic Nanoparticle-Based Immunoassays

Computer Numerical Control Micromilling of a Microfluidic Acrylic Device with a Staggered Restriction for Magnetic Nanoparticle-Based Immunoassays

Published on: June 23, 2022

Related Experiment Videos

Last Updated: Jun 18, 2026

Fluorescent Lateral Flow Immunoassay Based on Quantum Dots Nanobeads

Fluorescent Lateral Flow Immunoassay Based on Quantum Dots Nanobeads

Published on: June 28, 2024

Multiplexed Isothermal Amplification Based Diagnostic Platform to Detect Zika, Chikungunya, and Dengue 1

Multiplexed Isothermal Amplification Based Diagnostic Platform to Detect Zika, Chikungunya, and Dengue 1

Published on: March 13, 2018

Computer Numerical Control Micromilling of a Microfluidic Acrylic Device with a Staggered Restriction for Magnetic Nanoparticle-Based Immunoassays

Computer Numerical Control Micromilling of a Microfluidic Acrylic Device with a Staggered Restriction for Magnetic Nanoparticle-Based Immunoassays

Published on: June 23, 2022

Area of Science:

Biomedical Diagnostics
Point-of-Care Testing
Viral Antigen Detection

Background:

Current HIV diagnostic tests (NAT, ELISA p24) face challenges in resource-limited settings due to cost, infrastructure needs, and long turnaround times.
Existing self-performing lateral flow assays lack the analytical sensitivity of current ELISA technologies for HIV p24 detection.

Purpose of the Study:

To develop a novel lateral flow assay for HIV p24 antigen detection.
To achieve high analytical sensitivity and rapid results suitable for resource-limited settings.

Main Methods:

Development of a prototype lateral flow assay (LFA).
Evaluation of the LFA's analytical sensitivity for HIV p24 antigen.
Assessment of the assay's turnaround time.

Main Results:

The prototype lateral flow assay achieved sub-picogram per milliliter analytical sensitivity for HIV p24 antigen.
The assay provides results in under 40 minutes.
The developed LFA addresses key limitations of existing HIV diagnostic methods.

Conclusions:

The novel lateral flow assay demonstrates potential as a sensitive and rapid diagnostic tool for HIV p24 antigen.
This technology could significantly improve HIV diagnostics in resource-limited settings.
Further development may lead to a widely accessible and effective HIV screening method.